BWXT

BWX Technologies

Q1 FY2026 earnings · 2026-05-04$0.96 consensus

Summary

What they do:

Sole manufacturer of US naval nuclear reactors and a growing supplier of SMR components and nuclear fuel, sitting in L21 (Power Generation) as the defense-anchored nuclear technology company with an emerging commercial nuclear pathway.

Why they matter:

BWXT holds a legal monopoly on US naval nuclear reactor manufacturing — no other company has the clearance, facilities, or institutional knowledge to build reactors for submarines and aircraft carriers. The commercial angle: they manufacture components for SMR designs and produce TRISO fuel for advanced reactors that hyperscalers want for data center power.

Recent performance:

FY2025 revenue $3.2B (+18% YoY), Q4 EPS $1.08 (beat $0.89 estimate). Backlog $7.3B. Commercial segment backlog $1.7B (+85% YoY). FY2026 guidance: revenue ~$3.75B, EPS $4.55-4.70. Stock at ~$239, market cap ~$21.6B.

Our Verdict

Play TypeEstablished
Rel. ValueAttractive

Defense monopoly generating $3.2B in growing revenue, but at 52x forward P/E the market is pricing in commercial nuclear upside that remains 5-10 years from meaningful contribution.

Structural trends

Nuclear renaissance for data center powerSMR development accelerationUS defense spending growthHALEU/TRISO fuel demand

Structural

80

/ 100

Moat

8/10

Naval nuclear monopoly — sole US manufacturer, secured by clearance, regulation, and 70+ years of expertise

AI Exp.

Stub

~5% AI

Play Type

Established

AI Growth

~20%

Rel. Value

62

ATTRACTIVE

PriceLIVE

$238.27

+2.34%

Live via Yahoo Finance · refreshes every 5 min

Market Cap

$21.8B

P/E Ratio

66.7

P/S Ratio

6.8x

52W High

$239.64

52W Low

$99.63

52W Chg

139.2%

Beta

0.79

Supply Chain Dependencies

The Catch

BWXT's stock is priced for a nuclear future that hasn't arrived. The naval monopoly is real and growing, but it justifies perhaps half the current stock price. The other half is commercial nuclear optionality — SMR components, TRISO fuel, microreactors — that is 5-10 years from meaningful revenue. No commercial SMR has been deployed in the US. The NRC licensing timeline is measured in years, not quarters. If the nuclear renaissance is slower than the market expects, BWXT's 52x P/E compresses to 25-30x, and the stock loses 40-50% even as the underlying business continues to grow. The company is excellent; the question is whether the price is.

If They Win

If SMR deployment accelerates on the 2028-2030 timeline, BWXT becomes the nuclear equivalent of what TSMC is to semiconductors — the company that physically builds the reactors powering the AI economy. Revenue doubles to $6-8B as commercial manufacturing ramps alongside growing naval production. TRISO fuel becomes a chokepoint — BWXT is one of the few qualified producers. The company's 70+ years of nuclear engineering heritage translates into a manufacturing monopoly across both defense and commercial markets. Every hyperscaler nuclear PPA ultimately requires reactor components, and BWXT sits at the top of that supply chain. The US government's nuclear investments (IRA tax credits, DOE loan guarantees) and hyperscaler power commitments create a multi-decade demand runway with BWXT as the irreplaceable supplier.

Not financial advice. All scores generated via AI algorithms using public data.